The role of mitochondrial DNA in breast tumors

Nik-Zainal, 2016, Landscape of somatic mutations in 560 breast cancer whole-genome sequences, Nature, 534, 47, 10.1038/nature17676 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Warburg, 1927, The metabolism of tumors in the body, J. Gen. Physiol., 8, 519, 10.1085/jgp.8.6.519 Ju, 2014, Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer, Elife, 3, 10.7554/eLife.02935 Stewart, 2015, Simultaneous DNA and RNA mapping of somatic mitochondrial mutations across diverse human cancers, PLoS Genet., 11, 10.1371/journal.pgen.1005333 Larman, 2012, Spectrum of somatic mitochondrial mutations in five cancers, Proc. Natl. Acad. Sci. U. S. A., 109, 14087, 10.1073/pnas.1211502109 Reznik, 2016, Mitochondrial DNA copy number variation across human cancers, Elife, 5, 10.7554/eLife.10769 Grandhi, 2017, Heteroplasmic shifts in tumor mitochondrial genomes reveal tissue-specific signals of relaxed and positive selection, Hum. Mol. Genet., 26, 2912, 10.1093/hmg/ddx172 Robin, 1988, Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells, J. Cell Physiol., 136, 507, 10.1002/jcp.1041360316 Wiesner, 1992, Counting target molecules by exponential polymerase chain reaction: copy number of mitochondrial DNA in rat tissues, Biochem. Biophys. Res. Commun., 183, 553, 10.1016/0006-291X(92)90517-O Legros, 2004, Organization and dynamics of human mitochondrial DNA, J. Cell Sci., 117, 2653, 10.1242/jcs.01134 Wachsmuth, 2016, Age-related and heteroplasmy-related variation in human mtDNA copy number, PLoS Genet., 12, 10.1371/journal.pgen.1005939 Mansouri, 1999, An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice, Gastroenterology, 117, 181, 10.1016/S0016-5085(99)70566-4 Casula, 2005, Infection with HIV-1 induces a decrease in mtDNA, J. Infect. Dis., 191, 1468, 10.1086/429412 Brown, 1979, Rapid evolution of animal mitochondrial DNA, Proc. Natl. Acad. Sci. U. S. A., 76, 1967, 10.1073/pnas.76.4.1967 Lynch, 2006, Mutation pressure and the evolution of organelle genomic architecture, Science, 311, 1727, 10.1126/science.1118884 Johnson, 2001, Exonuclease proofreading by human mitochondrial DNA polymerase, J. Biol. Chem., 276, 38097, 10.1074/jbc.M106743200 Nikolaou, 2006, Deviations from Chargaff’s second parity rule in organellar DNA Insights into the evolution of organellar genomes, Gene, 381, 34, 10.1016/j.gene.2006.06.010 Calloway, 2000, The frequency of heteroplasmy in the HVII region of mtDNA differs across tissue types and increases with age, Am. J. Hum. Genet., 66, 1384, 10.1086/302844 He, 2010, Heteroplasmic mitochondrial DNA mutations in normal and tumour cells, Nature, 464, 610, 10.1038/nature08802 Samuels, 2013, Recurrent tissue-specific mtDNA mutations are common in humans, PLoS Genet., 9, 10.1371/journal.pgen.1003929 Li, 2015, Extensive tissue-related and allele-related mtDNA heteroplasmy suggests positive selection for somatic mutations, Proc. Natl. Acad. Sci. U. S. A., 112, 2491, 10.1073/pnas.1419651112 Alexandrov, 2013, Signatures of mutational processes in human cancer, Nature, 500, 415, 10.1038/nature12477 Nie, 2013, Mitochondrial common deletion, a potential biomarker for cancer occurrence, is selected against in cancer background: a meta-analysis of 38 studies, PLoS One, 8, 10.1371/journal.pone.0067953 Wei, 2002, Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging, Exp. Biol. Med., 227, 671, 10.1177/153537020222700901 Pavicic, 2009, Correlation analysis between mtDNA 4977-bp deletion and ageing, Mutat. Res., 670, 99, 10.1016/j.mrfmmm.2009.07.009 Kulawiec, 2008, Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion, Cancer Biol. Ther., 7, 1732, 10.4161/cbt.7.11.6729 Singh, 2005, Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis, Gene, 354, 140, 10.1016/j.gene.2005.03.027 Naito, 2008, Progressive tumor features accompany epithelial-mesenchymal transition induced in mitochondrial DNA-depleted cells, Cancer Sci., 99, 1584, 10.1111/j.1349-7006.2008.00879.x Moro, 2009, Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2, Cell Death Differ., 16, 571, 10.1038/cdd.2008.178 Guha, 2014, Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells, Oncogene, 33, 5238, 10.1038/onc.2013.467 Pelicano, 2006, Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism, J. Cell Biol., 175, 913, 10.1083/jcb.200512100 Yu, 2007, Depletion of mitochondrial DNA by ethidium bromide treatment inhibits the proliferation and tumorigenesis of T47D human breast cancer cells, Toxicol. Lett., 170, 83, 10.1016/j.toxlet.2007.02.013 Cavalli, 1997, Diminished tumorigenic phenotype after depletion of mitochondrial DNA, Cell Growth Differ., 8, 1189 Morais, 1994, Tumor-forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA, Cancer Res., 54, 3889 Magda, 2008, mtDNA depletion confers specific gene expression profiles in human cells grown in culture and in xenograft, BMC Genomics, 9, 521, 10.1186/1471-2164-9-521 Tan, 2015, Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA, Cell Metab., 21, 81, 10.1016/j.cmet.2014.12.003 Guo, 2011, Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer, Cancer Res., 71, 2978, 10.1158/0008-5472.CAN-10-3482 Bajzikova, 2019, Reactivation of dihydroorotate dehydrogenase-driven pyrimidine biosynthesis restores tumor growth of respiration-deficient cancer cells, Cell Metab., 29, 399, 10.1016/j.cmet.2018.10.014 Dong, 2017, Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells, Elife, 6, 10.7554/eLife.22187 Gaude, 2016, Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival, Nat. Commun., 7, 13041, 10.1038/ncomms13041 Ishikawa, 2008, ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis, Science, 320, 661, 10.1126/science.1156906 Feeley, 2015, Mitochondrial genetics regulate breast cancer tumorigenicity and metastatic potential, Cancer Res., 75, 4429, 10.1158/0008-5472.CAN-15-0074 Brinker, 2017, Mitochondrial haplotype alters mammary cancer tumorigenicity and metastasis in an oncogenic driver-dependent manner, Cancer Res., 77, 6941, 10.1158/0008-5472.CAN-17-2194 Garcia-Heredia, 2015, Decoding Warburg’s hypothesis: tumor-related mutations in the mitochondrial respiratory chain, Oncotarget, 6, 41582, 10.18632/oncotarget.6057 Goldhirsch, 2009, Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009, Ann. Oncol., 20, 1319, 10.1093/annonc/mdp322 Olivotto, 2005, Population-based validation of the prognostic model ADJUVANT! for early breast cancer, J. Clin. Oncol., 23, 2716, 10.1200/JCO.2005.06.178 Ravdin, 2001, Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer, J. Clin. Oncol., 19, 980, 10.1200/JCO.2001.19.4.980 Lundin, 2006, Generalisability of survival estimates for patients with breast cancer--a comparison across two population-based series, Eur. J. Cancer, 42, 3228, 10.1016/j.ejca.2006.06.028 Goldhirsch, 2006, First—select the target: better choice of adjuvant treatments for breast cancer patients, Ann. Oncol., 17, 1772, 10.1093/annonc/mdl398 Krop, 2017, Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology Clinical Practice Guideline focused update, J. Clin. Oncol., 35, 2838, 10.1200/JCO.2017.74.0472 Piccart-Gebhart, 2008, Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer, J. Clin. Oncol., 26, 1980, 10.1200/JCO.2007.10.8399 Giordano, 2018, Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: ASCO Clinical Practice Guideline update, J. Clin. Oncol., 36, 2736, 10.1200/JCO.2018.79.2697 Rugo, 2016, Endocrine therapy for hormone receptor-positive metastatic breast cancer: American Society of Clinical Oncology Guideline, J. Clin. Oncol., 34, 3069, 10.1200/JCO.2016.67.1487 Van Poznak, 2015, Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American Society of Clinical Oncology Clinical Practice Guideline, J. Clin. Oncol., 33, 2695, 10.1200/JCO.2015.61.1459 Mambo, 2005, Tumor-specific changes in mtDNA content in human cancer, Int. J. Cancer, 116, 920, 10.1002/ijc.21110 Yu, 2007, Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients, IUBMB Life, 59, 450, 10.1080/15216540701509955 Tseng, 2006, Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer, Genes Chromosomes Cancer, 45, 629, 10.1002/gcc.20326 Fan, 2009, Mitochondrial DNA content in paired normal and cancerous breast tissue samples from patients with breast cancer, J. Cancer Res. Clin. Oncol., 135, 983, 10.1007/s00432-008-0533-9 Barekati, 2010, Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations, Hum. Mol. Genet., 19, 2936, 10.1093/hmg/ddq199 McMahon, 2014, Mutational patterns in the breast cancer mitochondrial genome, with clinical correlates, Carcinogenesis, 35, 1046, 10.1093/carcin/bgu012 Weerts, 2016, Mitochondrial DNA content in breast cancer: impact on in vitro and in vivo phenotype and patient prognosis, Oncotarget, 7, 29166, 10.18632/oncotarget.8688 Weerts, 2017, Low tumor mitochondrial DNA content is associated with better outcome in breast cancer patients receiving anthracycline-based chemotherapy, Clin. Cancer Res., 23, 4735, 10.1158/1078-0432.CCR-17-0032 Ebrahimi, 2018, Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors, EXCLI J., 17, 149 Weerts, 2018, Mitochondrial RNA expression and single nucleotide variants in association with clinical parameters in primary breast cancers, Cancers, 10, 12, 10.3390/cancers10120500 Guha, 2018, Aggressive triple negative breast cancers have unique molecular signature on the basis of mitochondrial genetic and functional defects, Biochim. Biophys. Acta Mol. Basis Dis., 1864, 1060, 10.1016/j.bbadis.2018.01.002 Klinge, 2008, Estrogenic control of mitochondrial function and biogenesis, J. Cell Biochem., 105, 1342, 10.1002/jcb.21936 Conklin, 2004, Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness, Integr. Cancer Ther., 3, 294, 10.1177/1534735404270335 Ashley, 2009, Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs, Biochem. Biophys. Res. Commun., 378, 450, 10.1016/j.bbrc.2008.11.059 Shokolenko, 2009, Oxidative stress induces degradation of mitochondrial DNA, Nucleic Acids Res., 37, 2539, 10.1093/nar/gkp100 Hsu, 2010, Mitochondrial DNA content as a potential marker to predict response to anthracycline in breast cancer patients, Breast J., 16, 264, 10.1111/j.1524-4741.2010.00908.x Bai, 2011, Mitochondrial DNA content varies with pathological characteristics of breast cancer, J. Oncol., 496189 Lehle, 2014, LORD-Q: a long-run real-time PCR-based DNA-damage quantification method for nuclear and mitochondrial genome analysis, Nucleic Acids Res., 42, e41, 10.1093/nar/gkt1349 Podratz, 2011, Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons, Neurobiol. Dis., 41, 661, 10.1016/j.nbd.2010.11.017 Lim, 1987, Mitochondrial DNA damage by bleomycin, Biochem. Pharmacol., 36, 2769, 10.1016/0006-2952(87)90263-2 Larosche, 2007, Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver, J. Pharmacol. Exp. Ther., 321, 526, 10.1124/jpet.106.114546 Subashini, 2018, Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients, Indian J. Med. Res., 148, 207, 10.4103/ijmr.IJMR_1144_16 Masyeni, 2018, Evaluation of antiretroviral effect on mitochondrial DNA depletion among HIV-infected patients in Bali, HIV AIDS, 10, 145 Lemnrau, 2015, Mitochondrial DNA copy number in peripheral blood cells and risk of developing breast cancer, Cancer Res., 75, 2844, 10.1158/0008-5472.CAN-14-1692 Shen, 2015, Peripheral blood mitochondrial DNA copy number, length heteroplasmy and breast cancer risk: a replication study, Carcinogenesis, 36, 1307, 10.1093/carcin/bgv130 Campa, 2018, Mitochondrial DNA copy number variation, leukocyte telomere length, and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study, Breast Cancer Res., 20, 29, 10.1186/s13058-018-0955-5 Hu, 2016, Altered mitochondrial DNA copy number contributes to human cancer risk: evidence from an updated meta-analysis, Sci. Rep., 6, 35859, 10.1038/srep35859 Chae, 2018, Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study, Breast Cancer Res. Treat., 168, 713, 10.1007/s10549-017-4640-7 Tseng, 2011, Somatic mutations of the mitochondrial genome in human breast cancers, Genes Chromosomes Cancer, 50, 800, 10.1002/gcc.20901 Weerts, 2018, Tumor-specific mitochondrial DNA variants are rarely detected in cell-free DNA, Neoplasia, 20, 687, 10.1016/j.neo.2018.05.003 Wallace, 2013, Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease, Cold Spring Harb. Perspect. Biol., 5, 10.1101/cshperspect.a021220 Ruiz-Pesini, 2004, Effects of purifying and adaptive selection on regional variation in human mtDNA, Science, 303, 223, 10.1126/science.1088434 Mishmar, 2003, Natural selection shaped regional mtDNA variation in humans, Proc. Natl. Acad. Sci. U. S. A., 100, 171, 10.1073/pnas.0136972100